The vision
behind eXoZymes

Watch our CEO, Michael Heltzen, talk about
the bold vision behind our company.
What's the potential impact of exozymes?

Leadership Team

Our board of directors comprises seasoned professionals with extensive expertise, driving exceptional strategic leadership and governance.

 

Michael Heltzen, CEO

Michael Heltzen

CEO

Tyler Korman, Ph.D., Co-Founder and VP of Research

Tyler Korman, PhD

Co-Founder & VP of Research

Paul Opgenorth, Ph.D., Co-Founder and VP of Development

Paul Opgenorth, PhD

Co-Founder & VP of Development

Zach Karl, PhD, VP of Business Development

Zach Karl, PhD

VP of Business Development

Fouad Nawaz, VP of Finance

Fouad Nawaz

VP of Finance

Lasse H. Görlitz, VP of Communications

Lasse Görlitz

VP of Comms

The history of our company

Our co-founders, Tyler Korman, PhD, and Paul Opgenorth, PhD, share how the basic idea - liberating the enzymes from the confines of working in cells - was hatched in Jim Bowie's lab at UCLA, before being spun out as Invizyne in 2019, including some of the projects and challenges along the way.

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet consectetur. Integer eget magna mollis eleifend. Ullamcorper eu mauris luctus amet nullam. Feugiat mi libero lacus in ac magna turpis viverra.

Lorem ipsum dolor Lorem ipsum dolor

Come work with the most ambitious - and fun - team in biomanufacturing

Join us and work somewhere you can be yourself. And grow!

We are innovators and forward thinkers. We value creativity and appreciate your strength in executing the fundamentals.  Above all, we are motivated by our commitment to great work and to each other.  

We continue to grow. To learn more about opportunities to join our team, check back here often.

We currently do not have any open positions, but you're welcome to sign up below to get job alerts, once positions open.

Subscribe to updates

We are excited to keep you updated with news tailored to your preferences.

By subscribing to one or more streams, you'll receive information relevant to the areas you've selected. If you ever wish to update your preferences, you can do so at any time.

Latest news

investor press clippings science

Bloomberg TV: Jane King interviews co-founder and VP of Research, Dr. Tyler Korman

Read more
BioClick - an enzyme engineering game-changer
press release investor science

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

Read more
investor press clippings

World Bio Market Insights: eXoZymes appoints Damien Perriman as Chief Commercial Officer

Read more
investor video

Transcript: eXoZymes 4th quarter and full Year 2024 update from April 2, 2025

Read more

Policies

Polygon 2-1

Privacy Policy

Read policy here

Terms of Use

Read policy here

Financial conflicts of Interest for Sponsored Programs

Read policy here

Contact us

This text should be black